Combination of type 2 diabetes and sleep apnoea indicates eyesight loss within four years

July 4, 2017, University of Birmingham

Research led by the University of Birmingham has discovered that patients who suffer from both Type 2 diabetes and obstructive sleep apnoea are at greater risk of developing a condition that leads to blindness within an average period of less than four years.

Obstructive sleep apnoea (OSA) is a condition where the walls of the throat relax and narrow during sleep, resulting in snoring and interrupting breathing, and it is common in with Type 2 diabetes. Meanwhile, -the most common form of - affects between 40 and 50 per cent of patients with diabetes and is a leading cause of blindness in the Western world.

Previous studies have shown a link between OSA and diabetic . However, prior to this research led by the University of Birmingham, published in American Journal of Respiratory and Critical Care Medicine, there had been no published studies assessing the impact of OSA on the progression of diabetic retinopathy in patients with Type 2 diabetes.

Corresponding Author Doctor Abd Tahrani, of the University of Birmingham's Institute of Metabolism and Systems Research, said: "Despite improvements in glucose, blood pressure and lipid levels, diabetic retinopathy remains very common.

"Meanwhile, OSA has been shown to be very common in patients with Type 2 diabetes, which is not surprising considering that excess weight contributes to the development of both of these conditions.

"However, most patients who have OSA are not aware that they have the condition and the disease could go undiagnosed for years.

"Our study is the first to prospectively examine the impact of OSA on diabetic retinopathy.

"Firstly, we showed that sight-threatening diabetic retinopathy was more common in patients with both Type 2 diabetes and OSA compared to those with Type 2 diabetes but without OSA.

"However, more importantly, we have shown that patients with OSA and Type 2 diabetes, compared to those with diabetes only, are at increased risk of developing advanced diabetic retinopathy over a period of three years and seven months."

The study was carried out at two diabetes clinics at hospitals in the Midlands and involved 230 patients with Type 2 diabetes.

The study excluded any patients who were already known to have OSA or any kind of respiratory condition.

The patients were assessed for diabetic retinopathy using specialist retinal imaging, while OSA was assessed using a home-based, multi-channel cardio-respiratory portable device.

The results showed that diabetic retinopathy prevalence was higher in patients with OSA (42.9%) compared to those without OSA (24.1%).

The longitudinal study found that at a follow-up appointment, on average 43 months later, the patients with OSA (18.4%) were more likely to develop moderate to severe diabetic retinopathy compared to those without OSA (6.1%).

Meanwhile, the study also showed that patients who received treatment for OSA using a machine connected to a face mask that delivers pressure to prevent the blockage of the airways during sleep had a lower risk of developing advanced diabetic retinopathy compared to patients who did not receive the treatment.

Dr Tahrani added: "We can conclude from this study that OSA is an independent predictor for the progression to moderate or severe diabetic retinopathy in patients with Type 2 diabetes.

"Our findings are important because improved understanding of the pathogenesis of diabetic retinopathy is important in order to identify new treatments.

"Following our research, it is important that clinicians treating patients with Type 2 diabetes are aware that their patients who also have OSA are particularly at increased risk of developing advance retinopathy and, hence, appropriate preventative measures should be put in place.

"Clinicians should consider testing patients for OSA as OSA is very common in patients with Type 2 ."

Explore further: Many youths with diabetes not being screened as recommended for diabetic retinopathy

More information: Quratul A Altaf et al. Obstructive Sleep Apnoea and Retinopathy in Patients with Type 2 Diabetes: A Longitudinal Study, American Journal of Respiratory and Critical Care Medicine (2017). DOI: 10.1164/rccm.201701-0175OC

Related Stories

Many youths with diabetes not being screened as recommended for diabetic retinopathy

March 23, 2017
Many youths with type 1 and 2 diabetes are not receiving eye examinations as recommended to monitor for diabetic retinopathy, according to a study published online by JAMA Ophthalmology.

Mapping IDs geographic access barriers for diabetic retinopathy

May 25, 2017
(HealthDay)—Geographic information systems mapping can visualize geographic access barriers to eye care among patients with diabetes, while telescreening can increase the rate of diabetes retinopathy evaluation, according ...

Treated diabetic retinopathy rare in children with T1DM

October 19, 2016
(HealthDay)—Treated diabetic retinopathy (DR) is extremely rare among children with type 1 diabetes, according to research published online Oct. 7 in Diabetes Care.

Growth factor shown to protect the retina in early stage diabetes

February 2, 2017
Researchers from the Schepens Eye Research Institute of Massachusetts Eye and Ear have shown that a slight increase in transforming growth factor beta (TGF-β), which is present in preclinical animal models with diabetic ...

Researchers identify candidate biomarker of accelerated onset diabetic retinopathy

April 1, 2016
Researchers from Massachusetts Eye and Ear and Schepens Eye Research Institute have shown an association between a defective myogenic response—the regulatory increase or decrease in blood pressure to keep blood flow within ...

Diabetic retinopathy screening for children with type 1 diabetes should start later

September 1, 2015
A new study has found that the occurrence of advanced forms of a diabetic eye disease remains low among children living with diabetes, regardless of how long they have had the disease or their ability to keep blood sugar ...

Recommended for you

Scientists combine technologies to view the retina in unprecedented detail

November 14, 2018
By combining two imaging modalities—adaptive optics and angiography—investigators at the National Eye Institute (NEI) can see live neurons, epithelial cells, and blood vessels deep in the eye's light-sensing retina. Resolving ...

Eyepatch with dissolvable needles used to treat eye disease

November 12, 2018
A team of researchers affiliated with several institutions in Singapore has developed an eyepatch with dissolvable needles for use in treating eye diseases. In their paper published in the journal Nature Communications, the ...

Calcifications in the eye increase risk for progression to advanced AMD by more than six times

November 8, 2018
Calcified nodules in the retina are associated with progression to late stages of age-related macular degeneration (AMD). Experts from Queen's University Belfast, working in partnership with the University of Alabama of Birmingham ...

Traditional glaucoma test can miss severity of disease

November 8, 2018
The most common tests for glaucoma can underestimate the severity of the condition by not detecting the presence of central vision loss, according to a new Columbia University study.

New contact lens to treat eye injuries

November 5, 2018
A new therapeutic contact lens that acts as a bandage for eye surface injuries being developed by QUT researchers could soon fast track the healing of previously difficult to treat corneal wounds.

New study offers hope for patients suffering from a rare form of blindness

November 1, 2018
A new form of therapy may halt or even reverse a form of progressive vision loss that, until now, has inevitably led to blindness. This hyper-targeted approach offers hope to individuals living with spinocerebellar ataxia ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.